Evidence map›Paper›PMID 39482951›Full record

ArticleThe American journal of psychiatry2024

What Are the Genetic Building Blocks of Alcohol-Related Behaviors?

Joel Gelernter, Joseph D Deak

Abstract readEditorial
In one paragraph

Article in The American journal of psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Joel GelernterDepartment of Psychiatry (Gelernter, Deak) and Departments of Genetics and Neuroscience (Gelernter), Yale University School of Medicine, New Haven, CT; Department of Psychiatry, Veterans Affairs Connecticut Healthcare System, West Haven, CT (Gelernter, Deak).ORCID 0000-0002-4067-1859
Joseph D DeakDepartment of Psychiatry (Gelernter, Deak) and Departments of Genetics and Neuroscience (Gelernter), Yale University School of Medicine, New Haven, CT; Department of Psychiatry, Veterans Affairs Connecticut Healthcare System, West Haven, CT (Gelernter, Deak).ORCID 0000-0002-0540-6080

Funding

Translational Technologies CoreP50AA012870 · NIAAA · YALE UNIVERSITY · PI John H. Krystal · 2001 to 2026
$43.7M
Methamphetamine and Other Substance Use Disorder Genetics in ThailandR01DA037974 · NIDA · YALE UNIVERSITY · PI JOEL GELERNTER, Marc N Potenza · 2015 to 2026
$6.7M
7/7 Psychiatric Genomics Consortium: Advancing Discovery and ImpactR01DA054869 · NIDA · WASHINGTON UNIVERSITY · PI AGRAWAL, ARPANA, EDENBERG, HOWARD J · 2021 to 2025
$3.3M
Using novel data sources across genetic, biological, and social domains to refine genome-wide investigations of substance use disordersK01DA058807 · NIDA · YALE UNIVERSITY · PI Joseph D. Deak · 2024 to 2026
$543k
BLRD VA I01 BX006482CSRD VA I01 CX001849NIAAA NIH HHS P50 AA012870NIDA NIH HHS K01 DA058807NIDA NIH HHS R01 DA037974NIDA NIH HHS R01 DA054869
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AlcoholGeneticsSubstance-Related and Addictive Disorders

Identifiers

PMID39482951
PMCPMC12201992

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.